Open AccessIntravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study
Author(s) -
Krepler Katharina,
Ergun Erdem,
Sacu Stefan,
RichterMüksch Sibylla,
Wagner Julia,
Stur Michael,
Wedrich Andreas
Publication year - 2005
Publication title -
acta ophthalmologica scandinavica
Language(s) - English
Resource type - Journals
eISSN - 1600-0420
pISSN - 1395-3907
DOI - 10.1111/j.1600-0420.2005.00490.x
Subject(s) - medicine , branch retinal vein occlusion , triamcinolone acetonide , ophthalmology , visual acuity , acetonide , intraocular pressure , fluorescein angiography , optical coherence tomography , occlusion , retinal vein , macular edema , surgery
. Purpose: To evaluate treatment of macular oedema due to branch retinal vein occlusion (BRVO) with intravitreal triamcinolone acetonide.Methods: In a prospective case series, nine patients with macular oedema due to BRVO received an intravitreal injection of 4 mg triamcinolone acetonide. Examination included best‐corrected visual acuity (BCVA) for distance and reading, intraocular pressure (IOP) measurement, fluorescein angiography and high resolution imaging by optical coherence tomography, preoperatively and at 1 week, 1 month, 3 and 6 months postoperatively.Results: Preoperative mean BCVAs were 1.3 ± 0.8 for distance vision, and 1.1 ± 0.3 for reading acuity, respectively. A significant improvement in reading acuity was observed until 1 month (0.7 ± 0.4, p = 0.02). No significant reduction in mean macular thickness was observed.Conclusions: Intravitreal injection of triamcinolone acetonide led to a significant improvement in mean VA in patients with macular oedema due to BRVO. However, the significant effect was not permanent and persisted for only 1 month.